XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,527,397 | -7.3% | 44,713 | +4.5% | 0.00% | 0.0% |
| Q2 2023 | $1,647,492 | -3.0% | 42,792 | -9.9% | 0.00% | 0.0% |
| Q1 2023 | $1,699,131 | +177.5% | 47,475 | +205.7% | 0.00% | – |
| Q4 2022 | $612,268 | +46.5% | 15,528 | +34.1% | 0.00% | – |
| Q3 2022 | $418,000 | +21.9% | 11,578 | +2.7% | 0.00% | – |
| Q2 2022 | $343,000 | +3.9% | 11,273 | +4.7% | 0.00% | – |
| Q1 2022 | $330,000 | +0.6% | 10,771 | +2.5% | 0.00% | – |
| Q4 2021 | $328,000 | +218.4% | 10,513 | +55.8% | 0.00% | – |
| Q3 2021 | $103,000 | +368.2% | 6,748 | +464.2% | 0.00% | – |
| Q2 2021 | $22,000 | +4.8% | 1,196 | 0.0% | 0.00% | – |
| Q1 2021 | $21,000 | +16.7% | 1,196 | 0.0% | 0.00% | – |
| Q4 2020 | $18,000 | +38.5% | 1,196 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | -13.3% | 1,196 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | – | 1,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |